SPIRIT trial

The SPIRIT trial is a research study designed to evaluate whether a specific treatment, called intravesical BCG therapy, effectively prevents bladder cancer from recurring after surgery. It involves multiple hospitals and carefully compares patients receiving the BCG treatment to those who do not, to see if the therapy reduces tumor recurrence. The trial aims to provide clear evidence on the benefits and safety of BCG, helping doctors make informed treatment decisions for bladder cancer patients. Overall, it seeks to improve outcomes and standardize care for those affected by this disease.